Introduction
Myeloid differentiation is a closely regulated process, involving differentiation of Common Myeloid Progenitors (CMP) towards cells of both the granulocyte/macrophage lineage (GM), as well as the megakaryocyte/erythroid (ME)
lineage (1, 2) . The regulation of lineage commitment and differentiation has historically been explained by two models: signaling by lineage-specific hematopoietic cytokines (deterministic model), and a stochastic model, based on the activity of lineage-specific transcription factors (3) (4) (5) (6) (7) . With regard to GM-lineage progression and determination, CCAAT/enhancer binding protein (C/EBP) factors play an essential role. This is best illustrated in C/EBPα deficient mice, by reduced formation of neutrophils due to a defect at the level of the granulocyte/macrophage progenitor GMP (8) . Whereas C/EBPα is essential for instruction of the GMP towards differentiation of the granulocyte and the monocyte/macrophage lineage, C/EBPε is primarily involved in terminal granulocyte differentiation, for both neutrophils and eosinophils (9) (10) (11) (12) . C/EBPε is the most recently identified member of the C/EBP family of transcription factors and exclusively expressed in myeloid cells (13, 14) .
During neutrophil development, C/EBPε regulates transition from the promyelocytic stage to the myelocytic stage of differentiation, and is essential for secondary and tertiary granule formation (14) (15) (16) . C/EBPε deficiency, demonstrated in knockout murine models, resembles the clinical phenotype of patients with neutrophil-specific granule deficiency, characterized by an increase in circulating immature neutrophils and recurrent pyogenic infections (12, 17-19). As a result of differential RNA splicing and alternative translational start sites, human-C/EBPε is expressed as four protein isoforms (32 kDa, 30kDa, 27kDa, and 14kDa) that represent functionally different roles during myeloid differentiation. These functional differences; transcriptional 
Methods

Ethics statement
Umbilical cord blood (UCB) was collected after written informed consent was provided according to the principles expressed in the Declaration of Helsinki.
Protocols were approved by the Institutional Review Board of the University Medical Center Utrecht.
Patient samples
Bone marrow specimens were collected during a yearly control visit and bone marrow examination. Written informed consent was obtained from all parents.
Cell lines
COS, HL60 and NB4, cells were maintained according to standard protocols as described in the Supplementary Appendix. .
Antibodies, DNA constructs and reagents
Antibodies, DNA constructs, and reagents used are listed in the Supplementary Appendix.
Isolation, culture and transduction of human CD34+ cells.
The procedures used to isolate and differentiate human CD34+ cells have been described previously (34) . Bicistronic retroviral DNA constructs were utilized, expressing the gene of interest (C/EBPε, C/EBPε K121/198R, C/EBPε R121/198K and C/EBPε K15xR) and an Internal Ribosomal Entry Site (IRES) followed by the For personal use only. on October 4, 2017. by guest www.bloodjournal.org From gene encoding for green fluorescent protein (eGFP). Retroviral transductions were performed as previously described (35) .
Transfection of cells and luciferase assays
Luciferase assays were performed according to standard protocols as described in the Supplementary Appendix.
Immunoprecipitation and Western blotting
COS cells were cultured and transfected, followed by Flag-or HAimmunoprecipitation as described previously (36). For immunoprecipitation of endogenous C/EBPε, CD34+ cells were differentiated towards neutrophils during 10 days. Cells were lysed in RIPA lysis buffer and incubated with anti-C/EBPε antibody overnight at 4ºC. and incubated with protein A agarose beads (Invitrogen, Life Technologies, Bleiswijk, the Netherlands) the next day. Equal amounts of sample were analyzed by Western Blot, probed with the respective antibodies.
Immunocomplexes were detected using enhanced chemiluminescence (GE Healthcare, Zeist, the Netherlands), or with quantitative fluorescence technology (Odessey, LI-COR technology)
Confocal studies and proximity ligation assay (PLA)
The procedures used for confocal analysis have been described previously (36). For PLA, COS cells or UCB-derived neutrophils were fixed, blocked and incubated with primary anti-rabbit and anti-mouse antibody overnight. According to the manufacturer's protocol (Olink Bioscience, Uppsala, Sweden), cells were subsequently incubated with the secondary mouse PLUS and rabbit MINUS probe For personal use only. on October 4, 2017. by guest www.bloodjournal.org From for 1 hours at 37 ºC in a dark humidity chamber. Cells were washed 3 times in PLA buffer A (10 mM Tris-HCl pH 7.5, 150mM NaCl, 0.05% Tween in ddH20) followed by ligation for 30 minutes. Again cells were washed, followed by amplification and detection for 100 minutes at 37 ºC in a dark humidity chamber. After this, cells were washed 3 times in PLA buffer B (200 mM Tris-HCl pH 7.5, 100mM NaCl in ddH20) and 3 times in 1% buffer B. Dry cells were mounted in Mowiol 4-88 containing DAPI.
Cells were analyzed with a 63x objective on a Zeiss LSM 710 fluorescence microscope (Carl Zeiss, Oberkochen, Germany).
Mass spectrometry analysis
Mass spectrometry was performed according to standard protocols as described in the Supplementary Appendix.
Histochemical and lactoferrin staining of hematopoietic cells
The procedures used to analyze myeloid differention have been described previously (34) .
DNA binding assay
The used procedures for nuclear fractionation are described in the Supplementary Appendix. Double stranded biotinylated oligo's encoding a CEBPε specific or control DNA binding sequence were coupled to streptavidin agarose beads. Subsequently, oligo-coupled beads were incubated with nuclear fractions isolated from HEK293 cells expressing mutant Flag-CEBPε constructs in binding buffer (10 mM Hepes, 10 mM KCl, 0,1 mM EGTA, 80 mM NaCl, 1% NP40, 2 mM DTT, 1% HALT protease inhibitor cocktail). After incubation, beads were washed 5 times with PBS containing 
Quantitative PCR
Q-PCR experiments were performed as previously described (37). Primers are listed in Table S1 . To quantify the data, the comparative threshold cycle method was used.
Relative quantity was defined as 2 -ΔΔCt .
β 2M was used as reference gene.
Statistical analysis
Statistical analysis was performed using a one-way ANOVA test followed by a 
Results
C/EBPε is acetylated in neutrophils.
To investigate whether C/EBPε is acetylated, cells were transfected with an epitope tagged C/EBPε construct and acetylation was analyzed by immunoprecipitation and immunoblotting using an anti-acetyl lysine antibody (anti-AcK). A high basal level of C/EBPε acetylation was observed ( Figure 1A ). To validate the specificity of the antiacetyl lysine antibody, we constructed a lysine dead mutant of C/EBPε, in which all 15 lysines of C/EBPε were mutated into arginine residues. Mutating all lysines did not affect protein expression or stability, suggesting that this mutant protein is properly folded ( Figure S1 ). No acetylation of the lysine dead mutant was observed; the lower band was considered non-specific ( Figure 1A ). To determine whether endogenously expressed C/EBPε was also acetylated, we analyzed the myeloid cell lines HL60 and NB4. NB4 cells were pre-treated with retinoic acid (RA) for 4 days to increase C/EBPε expression (38). Protein lysates were prepared, followed by acetyl lysineimmunoprecipitation, and immunoblotting using a C/EBPε antibody. Compared to isotype control, we observed C/EBPε acetylation of the 32/30kD isoforms ( Figure   1B ), suggesting that C/EBPε is acetylated in these myeloid cell lines. In addition, CD34+ cells from umbilical cord blood (UCB) were differentiated towards neutrophils for 10 days, followed by analysis of C/EBPε acetylation proximity ligation assay (PLA, see methods). Given that a PLA signal can only be obtained when detection antibodies are in extremely close proximity, this technique enables the detection of post-translational modifications in their cellular context. At day 10 of neutrophil differentiation, cytospins were prepared, and cells were incubated with an anti-acetyl lysine antibody and anti-C/EBPε antibody. Following PLA, we observed a specific nuclear signal only upon incubation with both antibodies. While there is a theoretical possibility that this reflects the interaction of C/EBPε with another acetylated protein, these data suggest that C/EBPε is acetylated in neutrophil progenitor cells ( Figure   1C ).
Acetylation of C/EBPε is regulated by SIRT1 and p300.
Acetylation is regulated by lysine acetyltransferases (KAT) and lysine deacetylases (KDAC). To investigate the specific regulators of C/EBPε acetylation, we first This suggests that SIRT1 may regulate C/EBPε deacetylation. To further investigate the role of SIRT1 as a regulator of C/EBPε acetylation, we co-transfected SIRT1 with C/EBPε and again performed immunoprecipitation, followed by anti-acetyl lysine immunoblotting. Co-transfection with SIRT1 decreased the levels of C/EBPε acetylation, suggesting that SIRT1 deacetylates C/EBPε ( Figure 2B ).
Next, we investigated whether the ubiquitously expressed KAT p300 could acetylate C/EBPε. p300 was transfected together with C/EBPε, followed by immunoprecipitation, and immunoblotting as described before. A concentration dependent increase of C/EBPε acetylation upon co-transfection of p300 was observed, suggesting that p300 can mediate C/EBPε acetylation ( Figure 2C ). To determine whether C/EBPε also interacts with SIRT1 and p300, we investigated association of these proteins utilizing PLA. We observed specific PLA signal upon cotransfection of C/EBPε together with either SIRT1 or p300, but not in single transfection controls, demonstrating that SIRT1 and p300 both interact with C/EBPε ( Figure 2D and Figure S2 ). To investigate the role of SIRT1 in the regulation of endogenously expressed C/EBPε, CD34+ cells were differentiated towards neutrophils ex vivo. Cells were treated overnight with nicotinamide, followed by immunoprecipitation and PLA. Compared to control cells, treatment with NAM resulted in increased levels of acetylated C/EBPε, observed by both immunoblotting ( Figure 2E ) and PLA ( Figure 2F and Figure S3 ), suggesting that SIRT1 can regulate C/EBPε acetylation in human neutrophil precursors. Taken together, these data indicate that C/EBPε can be acetylated by p300 and deacetylated by SIRT1.
Acetylation of C/EBPε regulates transcriptional activity.
To investigate the functional role of C/EBPε acetylation, luciferase assays were performed utilizing a reporter plasmid containing the M-CSF receptor promoter; a canonical transcriptional target of C/EBPs (39) . Cells were transfected with epitopetagged C/EBPε or lysine "dead" C/EBPε K15xR in the absence or presence of p300 or SIRT1. Transfection of C/EBPε induced reporter activity, which was further increased upon co-transfection of p300, and decreased upon co-transfection of SIRT1. Moreover, transfection of C/EBPε K15xR resulted in no transcriptional activation ( Figure 3A ). In addition C/EBPε was transfected together with an increasing amount of the lysine-dead variant (K15xR), which resulted in a concentration-dependent inhibition of reporter activity ( Figure 3B ). This suggests that C/EBPε K15xR acts as a dominant-negative transcriptional regulator, or prevents binding of C/EBPε to the M-CSFR promotor. Taken together, these data suggest that C/EBPε acetylation is essential for transcriptional activation and that acetylation levels regulate transcriptional activity.
Under homeostatic conditions, CEBPε is exclusively localized in the nucleus. To investigate whether acetylation can regulate nuclear localization of C/EBPε, confocal analysis of cells co-transfected with C/EBPε and C/EBPε K15xR was performed.
C/EBPε and C/EBPε K15xR both localized in the nucleus, indicating that C/EBPε acetylation is not critical for nuclear localization ( Figure 3C ).
C/EBP proteins are characterized by a highly conserved basic-leucine zipper (bZIP) domain, which is in involved in homodimerization and heterodimerization of C/EBPs and essential for DNA binding. To determine whether acetylation is important for the dimerization potential of C/EBPε, co-immunoprecipitations were performed with epitope-tagged C/EBPε, and C/EBPε K15xR. We observed no differences in coimmunoprecipitation whether C/EBPε was co-transfected with either C/EBPε, or C/EBPε K15xR, and no effect on co-immunoprecipitation of C/EBPε K15xR with C/EBPε K15xR suggesting that acetylation of C/EBPε is also not important for dimerization capacity ( Figure 3D ). In summary these data suggest that C/EBPε acetylation modulates transcriptional activity, and is not specifically involved in dimerization-capacity or nuclear localization.
C/EBPε acetylation levels depend on acetylation of lysine 121 and 198.
Acetylation is a post-translational modification that is restricted to lysine residues.
C/EBPε (32/30kDa) contains fifteen lysine residues, located in all six functional domains. To define which lysines can be acetylated, a mass spectrometry analysis was performed. Briefly, C/EBPε was transfected together with p300, and cells were treated with NAM to increase acetylation levels. Lysates were prepared, followed by immunoprecipitation and SDS-PAGE. C/EBPε protein bands were isolated and processed for mass spectrometry analysis. We identified four acetylated lysines, including two lysines in the repression domain (RD) I (K100 and K121), 1 lysine between RD II and the basic region (BR) (K198), and 1 lysine (K202) in the BR, containing the DNA binding domain ( Figure 4A ).
To investigate the functional role of these specific lysines, we constructed single lysine mutants and "addback" mutants in both the wild-type and lysine-dead background respectively. To determine the role of these lysines in C/EBPε acetylation we transfected lysine mutant C/EBPε proteins together with p300 and performed immunoprecipitation followed by immunoblotting with the anti-acetyl lysine antibody. Compared to C/EBPε, we observed a clear decrease in total C/EBPε acetylation in the C/EBPε K121R and C/EBPε K198R mutants, while this was not observed in the C/EBPε K100R and C/EBPε K202R mutants ( Figure 4B ). To confirm these findings, C/EBPε, C/EBPε K15xR or the add-back mutants C/EBPε R100K, C/EBPε R121K, C/EBPε R198K, and C/EBPε R202K were transfected together with p300, followed by immunoprecipitation and immunoblotting. Compared to C/EBPε K15xR, a clear increase in acetylation was observed for C/EBPε R121K, and less pronounced effect for the C/EBPε R198K mutant ( Figure 4C ). Taken together these data suggest that K121 and K198 are important for C/EBPε acetylation.
To investigate whether acetylation of these specifc lysines is also functionally relevant, a luciferase assay was performed again utilizing both M-CSFR and also a lactoferrin promoter luciferase reporter, lactoferrin being a C/EBPε target gene.
Compared to reporter activity induced by C/EBPε, a significant decrease in transcriptional activity upon transfection of the C/EBPε K121R, C/EBPε K198R, and C/EBPε K121/198R mutants ( Figure 4D and Figure 4E ) was observed, while this was Figure 5D ). These effects were enhanced after transduction with the C/EBPε K15xR (lysine dead) mutant. Strikingly, these effects could be almost completely reversed after add-back of lysines 121 and 198, illustrated by an increase in the percentage of mature neutrophils and intracellular lactoferrrin expression ( Figure 5D ). Together, these data suggest that acetylation of K121 and K198 of C/EBPε, is important for neutrophil differentiation.
To confirm that these effects were C/EBPε specific, we analyzed the effects of the Taken together, these data suggest that during neutrophil development, the regulation of C/EBPε acetylation, predominantly K121 and K198, is important for C/EBPε transcriptional activity.
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Discussion
In the present study we have investigated the functional relevance of C/EBPε acetylation. Our data demonstrate that C/EBPε is acetylated, and that this modification is important for neutrophil maturation. We have previously demonstrated that modulating protein acetylation in CD34+ hematopoietic progenitors, by utilizing lysine deacetylase inhibitors (KDACi), affects cell fate decisions during myeloid development (34) . These data suggested that the effects were the result of regulation of both histone and non-histone proteins. demonstrated that the antibacterial function of both human and murine neutrophils could be increased by treatment with NAM, modulating the expression of C/EBPε, and downstream effectors (32) . In addition, and in agreement with our data, they demonstrate that C/EBPε acetylation levels can be increased by treatment with NAM.
In contrast to this study, we observed no increase in C/EBPε protein expression, which can be explained by differential C/EBPε expression in immature neutrophil precursors compared to activated neutrophils in the peripheral blood. Furthermore, in our study we demonstrate for the first time the specific functional role of C/EBPε acetylation. We demonstrate that modulation of C/EBPε acetylation levels by p300 and SIRT1, regulates transcriptional activation by C/EBPε. By mass spectrometry analysis we identified four acetylated lysines, and the functional effects we observed, could at least be partly allocated to acetylation of two specific lysines; K121 and K198. K121 is located in the repression domain I of C/EBPε, which has previously been identified as a key element of the conserved repression motif (RDM) of various C/EBP family members, including C/EBPβ (21, 31) . The regulation of C/EBPε For personal use only. on October 4, 2017. by guest www.bloodjournal.org From transcriptional activity has previously been associated with levels of K121 sumoylation, suggesting a delicate balance between repression, and the recruitment of coactivators, resulting in increased C/EBPε transcriptional activity (30, 31) . Based on our data, acetylation of K121 is important for DNA binding and transcriptional activity. This was confirmed by increased C/EBPε activity in luciferase reporter assays and the rescue of DNA binding utilizing a C/EBPε mutant in which lysine 121 was replaced by a glutamine residue (K121Q), mimicking acetylation ( Figure S4C and Figure S6 ). The balance between K121 acetylation, involved in DNA binding of C/EBPε (Figure 4) , and K121 sumoylation, involved in active repression, and recruitment of cofactors, could regulate RDM and RDI function and thereby modulate C/EBPε transcriptional activity. While mutating lysine 198 to arginine, mimicking deacetylation, resulted in a clear decrease in total C/EBPε acetylation and transcriptional activity (Figure 4) , the specific functional role of K198 acetylation still requires further investigation. K198 is located in close proximity to the DNA binding region, and a highly conserved residue between species and C/EBP family members, including C/EBPα and C/EBPβ. Since K121R and K15xR still retain some DNA binding activity ( Figure 4E and Figure S4C ), while heterodimerization capacity is unaffected ( Figure 3D ), this suggests that these lysine mutants, including K198R, potentially regulate protein-protein interactions, resulting in suppression of C/EBPε target genes.
Interestingly, while C/EBPε is indispensable for neutrophil maturation, 
